Obese and overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline ...
A large-scale phase 2b/3 trial testing the efficacy of a novel drug designed to prevent HIV infection has been cut short due to a combination of positive early data and disruptions caused by the COVID ...
Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results